Literature DB >> 7537575

Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis.

K Sekine1, J Ohta, M Onishi, T Tatsuki, Y Shimokawa, T Toida, T Kawashima, Y Hashimoto.   

Abstract

Intestinal Bifidobacterium species are thought to be beneficial in animal and human intestines. We studied the mechanisms of Bifidobacteria in antitumor activity using a cell wall preparation (WPG) of B. infantis (Cancer Res., 45, 1300, (1985)). WPG enhanced the in vitro antitumor activities of mouse peritoneal exudate cells elicited with proteose-peptone (P-PEC) and thioglycollate broth (TG-PEC), determined by cytostatic ([3H]thymidine uptake inhibition) and cytolytic ([3H]uridine release) assays. Tumor necrosis factor-alpha (TNF-alpha) and reactive nitrogen intermediates (RNI) play a role in such augmented cytotoxicity, because anti-TNF-alpha antibody almost completely blocked the increased cytolytic activity of P-PEC in the presence of WPG. Moreover, WPG induced RNI in the supernatant of TG-PEC in a dose-dependent manner. The mRNA expression of several cytokines (IL-1 beta, IL-6, IL-10, IFN-alpha and TNF-alpha) was induced in BALB/c mouse peritoneal cells 3 h after an intraperitoneal injection of WPG (3 h WPG-PEC). However, this expression disappeared from 24 h WPG-PEC, except for that of IFN-alpha. IFN-gamma was not induced. Kinetic studies of the tumor neutralizing activities of the WPG-PECs by means of the in vivo Winn assay revealed that the activity emerged at 1.5 h, became maximal at 3 h and disappeared at 24h. These results indicated that Bifidobacterial WPG is a Biological Response Modifier (BRM) with characteristics similar to those of other bacterial BRMs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537575     DOI: 10.1248/bpb.18.148

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions.

Authors:  Mikihiro Fujiya; Yutaka Kohgo
Journal:  Clin J Gastroenterol       Date:  2010-05-08

Review 2.  Applications of inulin and oligofructose in health and nutrition.

Authors:  Narinder Kaur; Anil K Gupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

3.  Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16.

Authors:  Min-Kyeong Cha; Do-Kyung Lee; Hyang-Mi An; Si-Won Lee; Seon-Hee Shin; Jeong-Hyun Kwon; Kyung-Jae Kim; Nam-Joo Ha
Journal:  BMC Med       Date:  2012-07-12       Impact factor: 8.775

4.  Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.

Authors:  Huicong Zhou; Zhiliang He; Changdong Wang; Tingting Xie; Lin Liu; Chuanyang Liu; Fangzhou Song; Yongping Ma
Journal:  Int J Mol Sci       Date:  2016-06-06       Impact factor: 5.923

5.  Stimulation of murine cell-mediated immunity by dietary administration of a cell preparation of Enterococcus faecalis strain KH-2 and its possible activity against tumour development in mice.

Authors:  Takamitsu Tsukahara; Shin-Ichi Nakamura; Gustavo A Romero-Pèrez; Makoto Ohwaki; Takaharu Yanagisawa; Tatsuhiko Kan
Journal:  Biosci Microbiota Food Health       Date:  2018-03-28

6.  Experimental Study of Retention on the Combination of Bifidobacterium with High-Intensity Focused Ultrasound (HIFU) Synergistic Substance in Tumor Tissues.

Authors:  Xuan Gao; Wenjuan Zou; Binglei Jiang; Die Xu; Yong Luo; Jie Xiong; Sijing Yan; Yaotai Wang; Yu Tang; Chun Chen; Huanan Li; Hai Qiao; Qi Wang; Jianzhong Zou
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

7.  Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines.

Authors:  Do Kyung Lee; Seok Jang; Mi Jin Kim; Jung Hyun Kim; Myung Jun Chung; Kyung Jae Kim; Nam Joo Ha
Journal:  BMC Cancer       Date:  2008-10-27       Impact factor: 4.430

8.  Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence.

Authors:  Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.